| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 2.04 | 0.00 (0.00%) | 1.32 - 2.15 | 34.6 thousand (Below Avg) |
Market data as of 2:30PM 06/19/13. Quotes are delayed by at least 15 min.
| Open | 2.04 |
|---|---|
| Previous Close | 2.04 |
| Day's Range | 2.02 - 2.05 |
| Market Cap | 63.4M |
| Avg Volume (10 Day) | 61.5K |
| Price/Earnings (Trailing 12 Mo.) | 51.0x |
| Earnings Per Share (Trailing 12 Mo.) | 0.04 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
Theragenics Corporation Extends Exclusivity Period Under Letter Agreement with Juniper Investment Company
Business Wire - Thursday 06/13/2013 8:47 AM ET
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Theragenics Corporation
Business Wire - Friday 05/24/2013 9:59 PM ET
Lifshitz Law Firm Announces Investigation of Chemed Corporation, Overhill Farms, Inc., Theragenics Corporation, and Websense, Inc.
PR Newswire - Wednesday 05/22/2013 6:47 PM ET
Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of Theragenics Corporation (TGX)
Business Wire - Monday 05/20/2013 7:00 PM ET
Theragenics Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Going Private Proposal
Business Wire - Monday 05/20/2013 12:21 PM ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Theragenics Corporation in Connection with a Going Private Proposal
Business Wire - Monday 05/20/2013 7:11 AM ET
| TGX | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -3.82% | |
| Net Income Growth (1yr) | -66.92% | |
| Total Debt/Equity | 0.29 | |
| LT Debt/Equity | 0.29 | |
| Earnings Yield | 1.96% | |
| Price/Sales | 0.78 |
| Company | Last | Change |
|---|---|---|
| EnteroMedics Inc | 1.21 | +2.54% |
| Span-America Medical Systems Inc | 19.96 | -0.65% |
| Edap Tms SA | 2.82 | -2.42% |
| Sunshine Heart Inc | 6.02 | -0.49% |
| Digirad Corp | 2.35 | -1.67% |
Data is delayed by at least 15 min.